These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1130 related items for PubMed ID: 21726136

  • 1. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S, Kushwaha S, Warsi MH, Anwar M, Ahmad MZ, Ahmad I, Talegaonkar S, Khan ZI, Khar RK, Ahmad FJ.
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [Abstract] [Full Text] [Related]

  • 2. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits.
    Attia IA, El-Gizawy SA, Fouda MA, Donia AM.
    AAPS PharmSciTech; 2007 Dec 14; 8(4):E106. PubMed ID: 18181527
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin.
    Imran M, Shah MR, Ullah F, Ullah S, Elhissi AM, Nawaz W, Ahmad F, Sadiq A, Ali I.
    Drug Deliv; 2016 Nov 14; 23(9):3653-3664. PubMed ID: 27886514
    [Abstract] [Full Text] [Related]

  • 5. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS, Mortada ND, Mansour S, Hathout RM.
    Int J Pharm; 2005 Dec 08; 306(1-2):71-82. PubMed ID: 16263229
    [Abstract] [Full Text] [Related]

  • 6. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP, Shenoy BD, Tiwari SB, Karki R, Udupa N, Kotian M.
    Indian J Exp Biol; 2000 Feb 08; 38(2):113-8. PubMed ID: 11218826
    [Abstract] [Full Text] [Related]

  • 7. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
    Lin T, Fang Q, Peng D, Huang X, Zhu T, Luo Q, Zhou K, Chen W.
    Drug Deliv; 2013 Feb 08; 20(7):277-84. PubMed ID: 24044645
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of niosomes containing ribavirin for liver targeting.
    Hashim F, El-Ridy M, Nasr M, Abdallah Y.
    Drug Deliv; 2010 Jul 08; 17(5):282-7. PubMed ID: 20350052
    [Abstract] [Full Text] [Related]

  • 9. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK, Palei NN.
    Indian J Exp Biol; 2011 Jun 08; 49(6):438-45. PubMed ID: 21702223
    [Abstract] [Full Text] [Related]

  • 10. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, Woo JS, Yong CS.
    Int J Pharm; 2009 Jul 30; 377(1-2):1-8. PubMed ID: 19394413
    [Abstract] [Full Text] [Related]

  • 11. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
    Mokhtar M, Sammour OA, Hammad MA, Megrab NA.
    Int J Pharm; 2008 Sep 01; 361(1-2):104-11. PubMed ID: 18577437
    [Abstract] [Full Text] [Related]

  • 12. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D, Madan JR, Gujar KN, Tupsamundre A, Ranpise HA, Dua K.
    Pharm Nanotechnol; 2018 Sep 01; 6(1):69-78. PubMed ID: 29380709
    [Abstract] [Full Text] [Related]

  • 13. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A, Raish M, Al-Jenoobi FI, Al-Mohizea AM.
    Curr Drug Deliv; 2018 Feb 14; 15(2):260-266. PubMed ID: 28521674
    [Abstract] [Full Text] [Related]

  • 14. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A, Imran Khan M, Ur Rehman M, Abbas G, Aslam N, Ahmad S, Abbas K, Akhtar Shah P, Iqbal M, Ahmed Al Subari AM, Shaheer T, Shah S.
    Int J Nanomedicine; 2020 Feb 14; 15():7937-7949. PubMed ID: 33116510
    [Abstract] [Full Text] [Related]

  • 15. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
    Patel KK, Kumar P, Thakkar HP.
    AAPS PharmSciTech; 2012 Dec 14; 13(4):1502-10. PubMed ID: 23104306
    [Abstract] [Full Text] [Related]

  • 16. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
    Moghassemi S, Hadjizadeh A, Hakamivala A, Omidfar K.
    AAPS PharmSciTech; 2017 Jan 01; 18(1):34-41. PubMed ID: 27502406
    [Abstract] [Full Text] [Related]

  • 17. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin.
    Ullah S, Shah MR, Shoaib M, Imran M, Elhissi AM, Ahmad F, Ali I, Shah SW.
    Drug Deliv; 2016 Nov 01; 23(9):3480-3491. PubMed ID: 27247018
    [Abstract] [Full Text] [Related]

  • 18. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride.
    Hasan AA.
    Pharm Dev Technol; 2014 Sep 01; 19(6):748-54. PubMed ID: 23964893
    [Abstract] [Full Text] [Related]

  • 19. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
    Soliman OAE, Mohamed EA, Khatera NAA.
    Pharm Dev Technol; 2019 Jan 01; 24(1):48-62. PubMed ID: 29210317
    [Abstract] [Full Text] [Related]

  • 20. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI, Abdelbary AA, Kandil SM, Mahmoud TM.
    Drug Dev Ind Pharm; 2019 Jul 01; 45(7):1157-1167. PubMed ID: 30919700
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.